Christopher M. Holman has been a Professor of Law at the University of Missouri-Kansas City since 2005. He has written and published extensively on topics relating to patent and copyright law and their intersection with biotechnology and pharmaceuticals. He has also authored multiple amicus briefs for the U.S. Court of Appeals of the Federal Circuit and U.S. Supreme Court in important intellectual property cases. He is the Executive Editor of the Biotechnology Law Report, and author of the publication’s bimonthly Holman Report. Professor Holman is also a senior scholar at the Center for Intellectual Property x Innovation Policy (C-IP2), housed at George Mason University, Anthony Scalia Law School.

Professor Holman has taught classes in patent law, copyright law, trademark law, intellectual property survey, antitrust, biotechnology and pharmaceutical law, and law science and technology. He is a faculty advisor for the law school’s Intellectual Property Emphasis Area, and helps oversee the Intellectual Property Clinic.

Prior to becoming a law professor, Holman served as vice-president of intellectual property and patent counsel at several Silicon Valley biotechnology companies and worked as an associate at a major intellectual property law firm. He was also a tenure-track chemistry professor in the California State University system. A native of California, Holman received his Ph.D. in biochemistry and molecular biology from the University of California at Davis, and engaged in post-doctoral drug discovery research at Roche Biosciences in Palo Alto, California. He then attended law school at UC Berkeley’s Boalt Hall, during which time he was an associate editor for the Berkeley Technology Law Journal and served as a full-time judicial extern in federal court in the Northern District of California.